NewsRoom
FDA approves $3.5 million treatment for hemophilia, now the most expensive ...
The US Food and Drug Administration on Tuesday approved Hemgenix, a new drug to treat hemophilia. Manufacturer CSL Behring set the...
Read More
Vaccines business potential in a post-COVID world
The COVID-19 pandemic has been a key catalyst to reinvigorate the global vaccines market as pharmaceutical companies, armed with d...
Read More
Truth seekers. Causality behind deaths in Gambia being investigated: WHO...
The World Health Organization said the causality behind the death of 66 children in Gambia was being investigated, even as serious...
Read More
Pill to prevent pre-eclampsia gets UK fast track for development...
A new pill that could prevent pre-eclampsia has become the first pregnancy drug to be fast-tracked for development by the UK’s d...
Read More
USFDA concludes inspection of Aurobindo Pharma's unit XI...
The inspection at Aurobindo Pharma's unit XI is concluded by the United States Food and Drug Administration, the firm said in a st...
Read More
Regulators come knocking on the doors of drug companies...
The last few months have seen several drugmakers outline remedial measures that they are undertaking, following action by the US r...
Read More
Chandigarh moves court against 3 pharma companies
The Drug Controller Office, UT, has filed a case in a local court against the directors and other officials of a Parwanoo-based ph...
Read More
Novavax says Omicron shot shows strong immune response as second booster...
Vaccine maker Novavax Inc (NVAX.O) said on Tuesday its COVID-19 shot retooled against the Omicron BA.1 variant showed a strong imm...
Read More